Document is current
Any future updates will be listed below
-
Authors
Palmer, Melissa
Seekins, Daniel
Avigan, Mark
Marcinak, John
Rockey, Don C.
Regev, Arie
Shastri, Vineet K.
Lewis, James H.
Dash, Ajit https://orcid.org/0000-0003-4033-4614
- License Information
-
More Information
Article History
Accepted: 13 July 2025
First Online: 5 August 2025
Declarations
:
: Not Applicable.
: Not Applicable.
: Not Applicable.
: Not Applicable.
: Data sharing is not applicable to this article as no datasets were generated or analysed.
: Data sharing is not applicable to this article as no datasets were generated or analysed.
: None.
: Drs. Palmer, Rockey, and Lewis serve as consultants to several pharmaceutical companies for activities related to DILI but have not derived any financial or other compensation from activities related to developing this document. Dr. Marcinak is an employee of AbbVie and owns stock in AbbVie. Drs. Seekins, Avigan, Regev, Shastri, and Dash have no conflicts of interest related to this paper. Dr.James Lewis is an Editorial Board member of Drug Safety. Dr.James Lewis was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.
: M. Palmer, D. Seekins, and A. Dash were involved in conceptualization, methodology, formal analysis, writing original draft as well as review and editing. M. Avigan, J. Marcinak, D.C. Rockey, Arie Regev, V. K. Shastri, and J.H. Lewis were involved in writing during review and editing. All authors read and approved the final version.
